Halal Pharmacore provides comprehensive services to help companies enter the halal pharmaceutical market, including market research, halal-compliant drug manufacturing processes, and acquiring halal certifications in various markets of interest.
We Are Trusted By World’s Leading Companies to Provide the Following Halal Pharmaceutical Services:
Halal Market News & Events
Halal Horizons: Future of Pharmaceutical Science at Taylor’s University
Taylor’s University’s programme teaches students to uphold halal practices in the cosmetic industry, preparing them for the expanding halal pharmaceutical sector.
Unleashing Potential: The Rise of the Global Halal Market
Experience the exponential growth of the global halal market, projected to reach $7.7 trillion by 2025. This surge is driven by sectors such as Islamic finance, food and beverage, pharmaceuticals, and more. With consumer spending on halal products expected to hit $2.4 trillion in 2024, the halal industry presents a promising economic sector for investment. Join us in this journey as we explore the untapped potential of the halal market
Unlocking the Halal Goldmine: Invest in the Philippine’s Thriving Halal Market
Philippines aims to become a premier halal hub by 2028, tapping into the $7.7 trillion global halal industry. The strategic plan includes increasing halal-certified products and generating PHP230 billion in domestic halal sector investments. This presents a thriving market for investors, with potential for significant domestic growth and job creation.
Halal Horizons: A Global Convergence at the Makkah Halal Forum
The Makkah Halal Forum, organized by the Islamic Chamber Halal Services and Manafea, is a pioneering event aimed at revolutionizing the global Halal Market. The forum will host workshops, panels, and exhibitions to address critical issues in the Halal economy and meet the needs of Muslim consumers. This 3-day event promotes cross-sector collaborations and drives the growth of the Halal market globally.
Duopharma Biotech: A Beacon of Innovation in Malaysia’s Healthcare Landscape, Celebrated by Frost & Sullivan
Duopharma Biotech Berhad, a pioneer in halal pharmaceuticals, was named the 2022 Malaysian Company of the Year. They’ve made strides in biosimilars, notably with ERYSAA® for anemia in kidney disease. With high customer satisfaction and a diverse portfolio, they’re setting industry standards.
State of the Global Islamic Economy Report 23/2024: A $142 Billion Opportunity
The halal pharmaceutical industry is experiencing significant growth, with Muslim consumer spending projected to reach $142 billion by 2027. Strategic partnerships, government initiatives, and advancements in AI are driving this expansion. The industry presents promising investment opportunities for sustainable growth.
We keep you posted with the latest news and events in the halal pharmaceutical space.
Market Directory
